John McCamant - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock John McCamant's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today

John McCamant

Verified

Editor, Medical Technology Stock Letter

San Francisco

Beats

Primary beats

Health

Secondary beats

Culture Dance Wellness Product Reviews B2B Celebrity Interviews Mental Health Other Sectors Technology Entertainment Solo Female Travel Art Consumer Goods IVF

Final Covers

psychotherapy, trauma burnout collective trauma,political polarization effective communication, the media and trauma second-hand trauma, PTSD conflict resolution, trauma healing

Journalist Type

Seniority Positions

Industries

Biotechnology

Medium Formats

Content

Total articles 34

Top Picks 2025: Skye Bioscience (SKYE)
By John McCamant · MoneyShow
Jan. 30, 2025
Top Picks 2025: Madrigal Pharmaceuticals (MDGL)
By John McCamant · MoneyShow
Jan. 29, 2025

As seen in

Medical Technology Stock Letter,Moneyshow,Bottom Line Inc.

Company Info

Medical Technology Stock Letter

San Francisco, United States

+1 510-843-1857